Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation
- 1 December 2002
- journal article
- case report
- Published by American Society of Hematology in Blood
- Vol. 100 (12) , 4236-4238
- https://doi.org/10.1182/blood-2002-03-0685
Abstract
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2)gene. Hemizygous males have microcytic anemia and iron overload. A 38-year-old male presented with this phenotype (hemoglobin [Hb] 7.6 g/dL, mean corpuscular volume [MCV] 64 fL, serum ferritin 859 μg/L), and molecular analysis of ALAS2 showed a mutation 1731G>A predicting an Arg560His amino acid change. A 36-year-old brother was hemizygous for this mutation and expressed the mutated ALAS2 mRNA in his reticulocytes, but showed almost no phenotypic expression. All 5 heterozygous females from this family, including the 3 daughters of the nonanemic hemizygous male, showed marginally increased red-cell distribution width (RDW). Although variable penetrance for XLSA in males has been previously described, this is the first report showing that phenotypic expression can be absent in hemizygous males. This observation is relevant to genetic counseling, emphasizing the importance of gene-based diagnosis.Keywords
This publication has 11 references indexed in Scilit:
- A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemiaClinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- Sideroblastic anaemiasBritish Journal of Haematology, 2002
- Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesisBritish Journal of Haematology, 1999
- Suppression of CDA II expression in a homozygoteBritish Journal of Haematology, 1999
- Four New Mutations in the Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) Gene Causing X-Linked Sideroblastic Anemia: Increased Pyridoxine Responsiveness After Removal of Iron Overload by Phlebotomy and Coinheritance of Hereditary HemochromatosisBlood, 1999
- Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24→q25 by in situ hybridizationCytogenetic and Genome Research, 1998
- Globin Chain Synthesis Analysis by High Performance Liquid Chroniatography in the Screening of Thalassemia SyndromesHemoglobin, 1998
- Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.Journal of Clinical Investigation, 1995
- A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemiaHuman Genetics, 1995
- X-linked Pyridoxine-Responsive Sideroblastic Anemia Due to a Thr388-to-Ser Substitution in Erythroid 5-Aminolevulinate SynthaseNew England Journal of Medicine, 1994